Travere Therapeutics, Inc. Common Stock (TVTX) is a publicly traded Healthcare sector company. As of July 11, 2026, TVTX trades at $55.73 with a market cap of $5.44B and a P/E ratio of -256.00. TVTX moved -3.20% today. Year to date, TVTX is +48.10%; over the trailing twelve months it is +241.93%. Its 52-week range spans $12.91 to $60.10. Analyst consensus is strong buy with an average price target of $58.33. Rallies surfaces TVTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TVTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $55.73 |
| Market Cap | $5.44B |
| P/E Ratio | -256.00 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $60.10 |
| 52-Week Low | $12.91 |
| Volume | 1.04M |
| Avg Volume | 0 |
| Revenue (TTM) | $536.20M |
| Net Income | $-21.42M |
| Gross Margin | 98.58% |
12 analysts cover TVTX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $58.33.